hippocampus. Given the function and the regional location of these receptors, it is not surprising that they have been closely linked with epilepsy: antagonists of GABA A receptors, such as bicuculline, promote seizures, whereas activators of these receptors, such as diazepam and stiripentol (3) , are used clini cally as antiseizure agents. In addition, mutations in Gabrd, the gene coding for the δ subunit of the GABA A receptor, appear to contribute to epilepsy susceptibility (4) .
Neuroactive steroids, or neuro steroids, act as positive al losteric modulators of GABA A receptors, potently enhancing the inhibitory effects of GABA (5) . While a detailed understand ing of how these molecules interact with GABA A receptors to modulate channel function has been generated for synaptic gcontaining receptors (6), structureactivity relationships of neuro steroids acting at extrasynaptic receptors has not been established. This represents critical missing information, since δsubunit-containing GABA A receptors appear preferentially sensitive to physiological GABA concentrations (7) , and neuro steroids exhibit reduced tonic current and decreased sensitivity in δsubunit knockout (δKO) mice (8) . The authors therefore set out to confirm the influence of the δsubunit of GABA A recep tors for GABAmediated tonic current, and to characterize the structureactivity relationship and functional consequences of neuro steroids acting at δcontaining GABA A receptors on I tonic . Synaptic GABA A receptors are primary mediators of rapid inhibition in the brain and play a key role in the pathophysiol ogy of epilepsy and other neurologic disorders. The δsubunit GABA A receptors are expressed extrasynaptically in the dentate gyrus and contribute to tonic inhibition, promoting network shunting as well as reducing seizure susceptibil ity. However, the neurosteroid structurefunction relationship at δGABA A receptors within the native hippocampus neurons remains unclear. Here we report a structureactivity relationship for neurosteroid modulation of extrasynaptic GABA A receptor-mediated tonic inhibition in the murine dentate gyrus granule cells. We recorded neurosteroid al losteric potentiation of GABA as well as direct activation of tonic currents using a wide array of natural and synthetic neurosteroids. Our results shows that, for all neurosteroids, the C3αOH group remains obligatory for extrasynaptic re ceptor functional activity, as C3βOH epimers were inactive in activating tonic currents. Allopregnanolone and related pregnane analogs exhibited the highest potency and maximal efficacy in promoting tonic currents. Alterations at the C17 or C20 region of the neurosteroid molecule drastically altered the transduction kinetics of tonic current activation. The androstane analogs had the weakest modulatory response among the analogs tested. Neurosteroid potentiation of tonic currents was completely (approximately 95%) diminished in granule cells from δknockout mice, suggesting that δsubunit receptors are essential for neurosteroid activity. The neurosteroid sensitivity of δGABA A receptors was confirmed at the systems level using a 6Hz seizure test. A consensus neurosteroid pharmacophore model at extrasyn aptic δGABA A receptors is proposed based on a structureactivity relationship for activation of tonic current and seizure protection.
Potentiating the Strength of Extrasynaptic Currents by Neurosteroid Hormones
First, using dissociated dentate gyrus granule cell neurons from wildtype (WT) and δsubunit KO mice, they show that the potentiating effects of allopregnanolone (AP), a wellstud ied neurosteroid, on GABAmediated inhibition is dramatically reduced in the absence of δsubunits, reaffirming previous reports of the preferential sensitivity for neuro steroids at δcontaining GABA A receptors. They then moved to hippocam pal slice preparations obtained from female WT and δKO mice in diestrus I stage. This consistency is important since variation in endogenous levels of steroid hormones, and consequently neuro steroids, and of δcontaining GABA A receptors, occurs throughout the ovarian cycle (9) . Measurement of tonic cur rent was achieved using the patchclamp technique, remov ing synaptic currents by treatment with the sodium channel inhibitor TTX. GABA (0.3-10 µm) dosedependently increased I tonic in WT slices, but only the highest concentration (10 µm) in creased tonic current in slices from δKO mice, which is beyond physiological GABA concentrations. Then, in the presence of 1 µm GABA, AP dosedependently enhanced I tonic , and this was far greater in WT slices than in δKO slices, supporting the results generated from the dissociated neuron prep.
They next assessed a library of endogenous and synthetic neurosteroid compounds for their ability to potentiate I tonic using WT slices. This allowed the rank order of potency of this collection of steroids to be established, and advances on most other research which typically investigates pregnanederived neuro steroids, such as AP or Tetrahydrodeoxycorticosterone (THDOC), in isolation. Furthermore, varying specific compo nents of the base neurosteroid structure facilitated structure activity relationships to be generated for the neurosteroid scaffold. They found that, in general, the pregnane neuro steroids were more potent than the androstanederived compounds, but that all (with one exception) neuro steroids consistently potentiated the effects of GABA on I tonic . In the next series of studies, the authors set out to establish whether the previously reported seizuresuppressing effects of neuro steroids (10) were related to the potentiation of extrasynaptic GABA A receptormediated tonic current. To test this, they employed the 6Hz model of electrically evoked seizures and studied a range of doses to establish the ED 50 for each of the neuro steroids from in the cellular assays. Most of the neuro steroids tested suppressed seizures in the model dose dependently, achieving 100% protection. Notably, the only compound that failed to achieve complete seizure suppres sion was 3β5αAP, and this was also the only compound that elicited no potentiation of GABA A receptor-mediated tonic current, even at high concentrations. In addition, the rank order of potency of the compounds was very similar between seizure suppression and potentiation of tonic current, strongly supporting that this in vivo measure is directly related to the electrophysiological action of neuro steroids.
Because the research covered a range of related naturally occurring and synthetic compounds, the authors summa rized the results of their studies by developing a pharmaco phore map describing the critical components that dictate the structurefunctional activity relationship of neuro steroids at extrasynaptic GABA A receptors. Five components of the structure were identified that dictate the efficacy and potency of neuro steroids. Of note, the C3αOH group of the neurosteroid remained essential for functional activity at ex trasynaptic receptors, whereas alterations of the C17 or C20 regions influenced the kinetics of tonic current activation. In the future, these components can be selectively manipu lated to develop new tools to study allosteric modulation of this receptor, and to identify novel therapeutic agents targeting epilepsy. Indeed, one of the synthetic neuro steroids investigated in the study is Ganaxolone, the most potent compound in the 6Hz anticonvulsant assay, and a drug which is currently in the endstages of clinical trials for epilepsy.
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